Default company panoramic image

AllTranz Inc.

AllTranz is developing a unique set of dermal delivery products utilizing proprietary technology platforms.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Lexington, KY, USA
  • Currency USD
  • Founded June 2007
  • Employees 8
  • Website

Company Summary

AllTranz is a specialty pharmaceutical company utilizing transdermal drug delivery technology to developing products addressing pain. The company is developing patent protected patch, gel, and microneedle products that offer many advantages to existing products on the market. The lead product is a THC prodrug patch, which is on the verge of entering human clinical trials. AllTranz products also incorporates abuse deterrent technology.


  • Default avatar
    Audra Stinchcomb
    Founder, CSO, & CEO

    Dr. Stinchcomb has more than 20 years experience in drug development, design and biomedical and transdermal research. Her academic credentials include degrees from the University of Michigan, the University of Colorado and postdoctoral experience at the University of California, San Francisco. Dr. Stinchcomb is currently a Professor at the University of Maryland School of Pharmacy. She is considered a leading expert in transdermal delivery.

  • Default avatar
    Steve Gailar
    Business Advisor & Board Member

    Steve Gailar is managing partner of Kentucky Seed Capital Fund. He has spent the last 30 years as a manager of, and investor in, various life sciences businesses. He has spent 14 years as a manager at Eli Lilly, 3 years as CEO of a bay area biotechnology startup, and 13 years as managing director of Senmend Medical Ventures. He has been founder/CEO of seven biomedical startups and has raised more than $50 million in venture capital financing.


  • Default avatar
    Foley & Lardner, LLP and Bingham Greenebaum Doll PLLC
    Default avatar
    DeSalvo & Co.

Previous Investors

  • Default avatar
    Kentucky Science and Technology|Kentucky Seed Capital, Bluegrass Angels, Commonwealth Seed Capital